智通财经APP讯，艾迪康控股(09860)发布截至2025年12月31日止年度的全年业绩，该集团期内取得收益26.38亿元(人民币，下同);母公司拥有人应占溢利1844.3万元;每股基本盈利0.03元。
投标方面，公司持续完善投标团队体系化建设，中标总额达6.7亿元，市场机会覆盖率达67%，重点客户保留率达91%。同时，公立三级医院中标数同比增长32%，公立二级医院中标数同比增长21%。展望未来，公司将进一步深化投标精细化管理，不断提升市场竞争力，全力抢抓优质业务机遇。
在数字化实验室建设方面，新一代LIMS系统已在全国所有实验室上线，实现临床实验室全流程数字化管理;PIMS系统已覆盖10家实验室，实现病理全流程与质量管控系统化;新一代NGS管理系统一期成功上线，标志着公司在特检业务标准化建设上取得重要突破。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.